Clinical and Procedural Evaluation of the Nile Croco® Dedicated Stent for Bifurcation – Six-month Clinical Follow-up Results of the Nile Croco Registry

Abstract

A true bifurcated lesion in coronary atherosclerotic disease is present in approximately 15% of patients referred for percutaneous coronary intervention (PCI).1 The percutaneous approach to this especially complex scenario has been faced in many different ways depending on the techniques available at any particular time.2–4 In the last few years, the introduction of drug-eluting stents (DES) has remarkably improved the outcome in bifurcation lesions compared with using bare-metal stents (BMS), resulting in fewer adverse events and lower main branch